Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled 'Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis' (Paz-Ares et al., J Cell Mol Med. 2010; 14(1-2): 51-69)

回复 Watkins 和 Rukazenkov (J Cell Mol Med 2010)，对题为“EGFR 突变 NSCLC 患者的临床结果：汇总分析”的稿件的回复信 (Paz-Ares 等人，J Cell Mol Med. 2010; 14(1-2): 51-69)